Portland, Ore. - May 15, 2018 - PRESS RELEASE - Cura, a provider of cannabis oil, has reached an agreement to produce a hemp-derived and a cannabis-derived line for Lenitiv. Today, Lenitiv’s hemp-derived CBD Capsules are available online and can be shipped widely. The product was developed and formulated by media personality and Mulitple Sclerosis (MS) survivor Montel Williams—one of the highest-profile medical cannabis patients in the United States.
Shortly before his diagnosis with MS in 1999, Williams had been on the set of Touched By An Angel filming an episode he guest starred in when his feet “caught fire.” Soon thereafter, Williams was diagnosed and learned that the all-consuming burning sensation in his feet was intractable neuropathic pain. After exhausting traditional remedies, Williams’ MS specialist, a neurologist, suggested he try medicinal cannabis, an idea he initially resisted, until he discovered that medical cannabis made the pain in his feet bearable. The Lenitiv brand benefits from Williams’ nearly two decades as a medical cannabis patient and was designed with his experience in mind.
Cura will produce Lenitiv products, starting with a hemp-derived CBD line, which launches nationwide today. Separately, Cura will produce Lenitiv’s cannabis-derived line which will be available with a number of new products this summer in Oregon and California in compliance with relevant state laws.
Lenitiv CBD Capsules are 100 percent hemp-derived and contain zero THC. Each bottle contains 30 gel capsules with 50mg of CBD each. Available in two options, Alert is designed to take in the morning, while Relax is designed to consume at night:
- Alert: Formulated with terpenes known to: aid anxiety, depression, pain management; act as an anti-inflammatory and soothe stress; promote alertness and memory retention
- Relax: Formulated with terpenes known to enhance mood, promote relaxation and restful sleep, quell anxiety, depression and insomnia; act as an antioxidant and anti-inflammatory.
“I’m excited to announce our agreement with Cura,” said David Racz, CEO of Lenitiv Scientific. “When I partnered with Montel to help him make his patient-focused vision a reality, we realized we would need like-minded partnerships that understood and shared the values that underpin it. Cura not only shares that vision but expresses it in their culture.”
Cura’s mission is to become the leading provider of cannabis oil in every market it enters and to become the first cannabis company with a billion-dollar valuation. Known for producing Select, the best-selling cannabis brand on the West Coast (CA/OR/NV, according to BDS Analytics), Cura looks forward to offering new and diverse products to the market through wholesale and white label agreements.
“When we first began talking to Montel and his team at Lenitiv, we were drawn to their people-focused vision,” said Cameron Forni, Cura’s president and co-founder. “We’re really excited about this partnership because the values that underpin Lenitiv are synergistic with ours. It’s also an opportunity for us to support and participate in Montel’s advocacy for common sense cannabis reform, and we’re thrilled to welcome Montel and the team at Lenitiv to our family.”
Lenitiv CBD Capsules are available online and ship nationally. Visit www.lenitivproducts.com to purchase.
